CoChat

The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.

Secondary adrenal insufficiency and pituitary dysfunction in oral/transdermal opioid users with non-cancer pain

Lamprecht, Andrea, Sorbello, Jane, Jang, Christina, Torpy, David J, Inder, Warrick J · 2018 · European Journal of Endocrinology

Abstract

Objective: To evaluate pituitary function, sexual function and quality of life (QoL) in patients on oral or transdermal opioids. Design and methods: Cross-sectional study comparing pituitary function, QoL and sexual function in people on long-term opioid therapy (n = 40) vs an age- and sex-matched control group (n = 25). Baseline pituitary function was assessed on blood samples collected prior to 0900 h. Further testing with corticotropin (250 µg IV) and metyrapone (30 mg/kg) stimulation tests was undertaken on participants with serum cortisol <250 nmol/L. Validated questionnaires completed to assess QoL, fatigue and sexual function. Results: Secondary adrenal insufficiency (SAI) was identified on the basis of a failed stimulation test in 22.5% of opioid users vs no controls (P = 0.01). Opioid users with SAI had a higher median morphine-equivalent daily dose (MEDD),P = 0.037 – 50% with MEDD >200 mg and 0% with MEDD <60 mg had SAI. Among male participants, testosterone was inversely associated with BMI (P = 0.001) but not opioid use. A non-significant trend to low testosterone <8 nmol/L in male opioid users (11/24 opioid users vs 2/14 control,P = 0.08) suggests a small subgroup with opioid-induced androgen deficiency. Opioid users had greater fatigue, reduced quality of life in all subsections of the SF-36 and impaired sexual function in both males and females (all scores P < 0.001 compared to controls). Conclusion: Long-term opioid therapy was associated with dose-related SAI in over 20% of chronic pain patients and is associated with poor quality of life, fatigue and sexual dysfunction. Obesity confounds the interpretation of opioid-induced male androgen deficiency.

Overview

Integrity signals

Registry

Crossref · 10.1530/eje-18-0530

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

2 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

Show all 42 references

Research works printed but not linked: 42

  1. 2010, Measuring fatigue in clinical and community settings, Journal of Psychosomatic Research, 69, 17, 10.1016/j.jpsychores.2009.10.007 · DOI · Paper page
  2. 2000, Use, misuse and abuse of androgens. The Endocrine Society of Australia consensus guidelines for androgen prescribing, Medical Journal of Australia, 172, 220, 10.5694/j.1326-5377.2000.tb123913.x · DOI
  3. 2016, Diagnosis and treatment of primary adrenal insufficiency: an endocrine society clinical practice guideline, Journal of Clinical Endocrinology and Metabolism, 101, 364, 10.1210/jc.2015-1710 · DOI · Paper page
  4. 2015, Opioid analgesic prescribing in Australia: a focus on gender and age, Pharmacoepidemiology and Drug Safety, 24, 628, 10.1002/pds.3767 · DOI
  5. 2009, Oral opioids for chronic non-cancer pain: higher prevalence of hypogonadism in men than in women, Experimental and Clinical Endocrinology and Diabetes, 117, 38
  6. 2006, The impact of hypogonadism and autonomic dysfunction on fatigue, emotional function, and sexual desire in male patients with advanced cancer: a pilot study, Cancer, 107, 2949, 10.1002/cncr.22339 · DOI · Paper page
  7. 2015, Effects of testosterone replacement in men with opioid-induced androgen deficiency: a randomized controlled trial, Pain, 156, 280, 10.1097/01.j.pain.0000460308.86819.aa · DOI · Paper page
  8. 1995, Elevated basal adrenocorticotropin and evidence for increased central opioid tone in highly trained male athletes, Journal of Clinical Endocrinology and Metabolism, 80, 244
  9. 2007, Secondary adrenal failure and secondary amenorrhoea following hydromorphone treatment, Clinical Endocrinology, 66, 604, 10.1111/j.1365-2265.2007.02779.x · DOI · Paper page
  10. 2005, Chronic fentanyl application induces adrenocortical insufficiency, Journal of Internal Medicine, 257, 478, 10.1111/j.1365-2796.2005.01483.x · DOI · Paper page
  11. Opioid, complications side effects, Pain Physician, 200811
  12. 2000, Comparison of one week 0900 h serum cortisol, low and standard dose synacthen tests with a 4 to 6 week insulin hypoglycaemia test after pituitary surgery in assessing HPA axis, Clinical Endocrinology, 53, 431, 10.1046/j.1365-2265.2000.01106.x · DOI
  13. 2017, Treatment of hypogonadism: current and future therapies, F1000 Research, 6, 68, 10.12688/f1000research.10102.1 · DOI · Paper page
  14. 2008, Opioid endocrinopathy in women consuming prescribed sustained-action opioids for control of nonmalignant pain, Journal of Pain, 9, 28, 10.1016/j.jpain.2007.08.005 · DOI · Paper page
  15. 2018, Characterization of the serum and salivary cortisol response to the intravenous 250 microg ACTH1-24 stimulation test, Endocrine, 59, 520, 10.1007/s12020-017-1505-0 · DOI
  16. 1997, The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction, Urology, 49, 822, 10.1016/S0090-4295(97)00238-0 · DOI · Paper page
  17. 2010, The effects of opioids and opioid analogs on animal and human endocrine systems, Endocrine Reviews, 31, 98, 10.1210/er.2009-0009 · DOI · Paper page
  18. 1985, Effect of naloxone on the hormone response to CRF in normal man, Endocrine Research, 11, 39, 10.3109/07435808509035423 · DOI
  19. 1997, Which patients benefit from provocative adrenal testing after transsphenoidal pituitary surgery?, Clinical Endocrinology, 46, 21, 10.1046/j.1365-2265.1997.d01-1748.x · DOI
  20. 1993, Differential changes in serum concentrations of androgens and estrogens (in relation with cortisol) in postmenopausal women with acute illness, Journal of Clinical Endocrinology and Metabolism, 76, 1542
  21. 2014, Chronic stress, cortisol dysfunction, and pain: a psychoneuroendocrine rationale for stress management in pain rehabilitation, Physical Therapy, 94, 1816, 10.2522/ptj.20130597 · DOI · Paper page
  22. 2015, Low-dose hydrocortisone replacement improves wellbeing and pain tolerance in chronic pain patients with opioid-induced hypocortisolemic responses. A pilot randomized, placebo-controlled trial, Psychoneuroendocrinology, 56, 157, 10.1016/j.psyneuen.2015.03.015 · DOI · Paper page
  23. 2009, Secondary adrenal insufficiency due to opiate therapy – another differential diagnosis worth consideration, Experimental and Clinical Endocrinology and Diabetes, 117, 649, 10.1055/s-0029-1202851 · DOI · Paper page
  24. 2011, Opioid-induced biochemical alterations of the neuroendocrine axis, Expert Review of Endocrinology and Metabolism, 6, 705, 10.1586/eem.11.55 · DOI
  25. 2017, New diagnostic criteria for subclinical hypercortisolism using postsurgical hypocortisolism: the Co-work of Adrenal Research study, Clinical Endocrinology, 86, 10, 10.1111/cen.13145 · DOI
  26. 2008, Prospective evaluation of a protocol for reduced glucocorticoid replacement in transsphenoidal pituitary adenomectomy: prophylactic glucocorticoid replacement is seldom necessary, Clinical Endocrinology, 68, 29, 10.1111/j.1365-2265.2007.02995.x · DOI
  27. 2011, General Health Questionnaire – 28 (GHQ-28), Journal of Physiotherapy, 57, 259, 10.1016/S1836-9553(11)70060-1 · DOI · Paper page
  28. 1990, Metyrapone effects on β-endorphin, ACTH and cortisol levels after chronic opiate receptor stimulation in man, Neuropeptides, 15, 129, 10.1016/0143-4179(90)90143-M · DOI
  29. 2016, Adrenal insufficiency in patients on long-term opioid analgesia, Clinical Endocrinology, 85, 831, 10.1111/cen.13125 · DOI · Paper page
  30. 2010, Opioid endocrinopathy: a clinical problem in patients with chronic pain and long-term oral opioid treatment, Clinical Journal of Pain, 26, 374, 10.1097/AJP.0b013e3181d1059d · DOI · Paper page
  31. 2004, Symptomatic hypogonadism in male survivors of cancer with chronic exposure to opioids, Cancer, 100, 851, 10.1002/cncr.20028 · DOI · Paper page
  32. 2011, Tramadol-induced adrenal insufficiency, European Journal of Clinical Pharmacology, 67, 865, 10.1007/s00228-011-0992-9 · DOI
  33. 2000, The low dose ACTH stimulation test is less sensitive than the overnight metyrapone test for the diagnosis of secondary hypoadrenalism, Clinical Endocrinology, 53, 221, 10.1046/j.1365-2265.2000.01057.x · DOI · Paper page
  34. 1986, Interference of endogenous B endorphin with opiate binding in the anterior pituitary, Neuropeptides, 8, 377, 10.1016/0143-4179(86)90009-0 · DOI
  35. 2017, The role of testosterone supplemental therapy in opioid-induced hypogonadism: a retrospective pilot analysis, American Journal of Men’s Health, 11, 1208, 10.1177/1557988316672396 · DOI · Paper page
  36. 2002, Hypogonadism in men consuming sustained-action oral opioids, Journal of Pain, 3, 377, 10.1054/jpai.2002.126790 · DOI · Paper page
  37. 2006, DHEAS deficiency during consumption of sustained-action prescribed opioids: evidence for opioid-induced inhibition of adrenal androgen production, Journal of Pain, 7, 901, 10.1016/j.jpain.2006.04.011 · DOI
  38. 2000, Endocrine consequences of long-term intrathecal administration of opioids, Journal of Clinical Endocrinology and Metabolism, 85, 2215, 10.1210/jcem.85.6.6615 · DOI · Paper page
  39. 2000, The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function, Journal of Sex and Marital Therapy, 26, 191, 10.1080/009262300278597 · DOI · Paper page
  40. 2017, Prospective evaluation of a week one overnight metyrapone test with subsequent dynamic assessments of hypothalamic-pituitary-adrenal axis function after pituitary surgery, Clinical Endocrinology, 87, 35, 10.1111/cen.13334 · DOI
  41. 1987, Autoradiographic differentiation of mu, delta, and kappa opioid receptors in the rat forebrain and midbrain, Journal of Neuroscience, 7, 2445
  42. 1993, The RAND 36-Item Health Survey 1.0, Health Economics, 2, 217, 10.1002/hec.4730020305 · DOI · Paper page

Cited by

See all 52

Metadata

Authors
Lamprecht, A., Sorbello, J., Jang, C., Torpy, D. J., & Inder, W. J.
Affiliations
  • The University of Queensland (AU)
  • Princess Alexandra Hospital (AU)
  • Royal Adelaide Hospital (AU)
Corresponding author
Inder, Warrick J
Venue
European Journal of Endocrinology
Published
2018-12
Volume
179
Issue
6
Pages
353-362
ISSN
  • 0804-4643 (ISSN-L)
  • 1479-683X
OpenAlex
W2890361357
Cited by
52
References
42
Citations by year
2026: 3 · 2025: 3 · 2024: 6 · 2023: 6 · 2022: 7 · 2021: 7 · 2020: 8 · 2019: 11 · 2018: 1
FWCI
5.37
Type
journal article
Language
en
Open access
closed
Locations
  • European Journal of Endocrinology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
Keywords
secondary adrenal insufficiency, pituitary dysfunction, long-term opioid therapy, transdermal opioids, chronic non-cancer pain, quality of life, sexual dysfunction, fatigue, testosterone, androgen deficiency, obesity, morphine equivalent daily dose, cortisol, ACTH stimulation test
MeSH terms
Administration, Cutaneous, Administration, Oral, Adrenal Insufficiency, Adult, Aged, Analgesics, Opioid, Cross-Sectional Studies, Female, Humans, Male, Middle Aged, Pituitary Gland, Pituitary Hormones, Quality of Life, Sexual Dysfunction, Physiological, Young Adult, Chronic Pain

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Secondary adrenal insufficiency and pituitary dysfunction in oral/transdermal opioid users with non-cancer pain. https://app.cochat.ai/papers/10.1530/eje-18-0530
The paper
Lamprecht, A., Sorbello, J., Jang, C., Torpy, D. J., & Inder, W. J. (2018). Secondary adrenal insufficiency and pituitary dysfunction in oral/transdermal opioid users with non-cancer pain. European Journal of Endocrinology. https://doi.org/10.1530/eje-18-0530

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.